Curia Refinances Senior Credit Facilities To Drive Ongoing Growth

KUALA LUMPUR, March 11 (Bernama) -- Curia Global Inc (Curia), a contract research, development, and manufacturing organisation, has refinanced its senior secured credit facilities to strengthen its financial position and support future growth.

The refinancing provides the company with additional capital and extends the maturity of its credit facilities, enabling it to capitalise on opportunities in drug development and manufacturing while advancing its mission of bringing life-changing therapies to market.

Curia Chief Executive Officer, Philip Macnabb in a statement said the refinancing demonstrates the confidence its lenders and investors have in the company.

bootstrap slideshow

"The new credit facility will enable us to continue investing in key growth projects that enhance our differentiated capabilities and deliver greater value for our customers," he said.

Curia's recent growth initiatives include a major investment in its Rensselaer, New York facility to expand capacity for producing complex active pharmaceutical ingredients.

Additionally, the company has invested in advanced sterile fill-finish technology at its Albuquerque, New Mexico site, with plans to expand these capabilities in Glasgow, United Kingdom, to more than double the current good manufacturing practice (GMP) batch size.

bootstrap slideshow

Curia has over 30 years of experience, with an integrated network of more than 20 global sites and over 3,100 employees partnering with biopharmaceutical customers to bring life-changing therapies to market.

-- BERNAMA